Paion
Aachen, Germany · $18.8M raised
- Total Funding
- $18.8M
- Last Round
- $8.9M Corporate RoundJan 2021
- Rounds
- 2
About
PAION AG is a publicly listed specialty pharmaceutical company focused on developing innovative medications for sedation, anesthesia, and critical care. The company pipeline includes remimazolam, which has received market approvals in multiple markets.
Summary
Paion is a Biotech company based in Aachen, Germany. It has raised $18.8M in total across 2 rounds, most recently a $8.9M Corporate Round round in Jan 2021. Investors include European Investment Bank.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...